Dr. David Cherney
Claim this profileToronto General Hospital
Studies Kidney Disease
Studies Diabetes
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials David Cherney is currently running
Retatrutide
for Obesity
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m\^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.
Recruiting1 award Phase 32 criteria
Tirzepatide
for Obesity and Chronic Kidney Disease
This trial is testing tirzepatide to see if it can help people with obesity, with or without type 2 diabetes, who have chronic kidney disease. The medication works by controlling blood sugar and reducing weight, which may improve kidney function. Tirzepatide is a new medication given regularly, effective in treating obesity in patients with and without diabetes.
Recruiting0 awards Phase 2
More about David Cherney
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments David Cherney has experience with
- Sotagliflozin
- Zibotentan
- Dapagliflozin
- Ambrisentan
- Tirzepatide
- Placebo
Breakdown of trials David Cherney has run
Kidney Disease
Diabetes
Chronic Kidney Disease
Diabetic Kidney Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Cherney specialize in?
David Cherney focuses on Kidney Disease and Diabetes. In particular, much of their work with Kidney Disease has involved treating patients, or patients who are undergoing treatment.
Is David Cherney currently recruiting for clinical trials?
Yes, David Cherney is currently recruiting for 2 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that David Cherney has studied deeply?
Yes, David Cherney has studied treatments such as Sotagliflozin, Zibotentan, Dapagliflozin.
What is the best way to schedule an appointment with David Cherney?
Apply for one of the trials that David Cherney is conducting.
What is the office address of David Cherney?
The office of David Cherney is located at: Toronto General Hospital, Toronto, Ontario M5G 2N2 Canada. This is the address for their practice at the Toronto General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.